Pharmacotherapy and Intensive Treatment - 2
Completed · Phase 4
Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders
In brief
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Key facts
- Study ID
- NCT00000218
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 353
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Kansas — Kansas City, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.